Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
The “Clawback:” State Financing of Medicare Drug Coverage

This issue paper describes the origins of the clawback, the formula by which each state’s clawback amount is calculated, and the clawback’s implications for states and for low-income Medicare beneficiaries. Issue Paper (.pdf)

The President’s FY 2005 Budget Proposal:  Overview and Briefing Charts

The President's FY 2005 Budget Proposal: Overview and Briefing ChartsThe overview and briefing charts present information on the President's FY 2005 budget proposal to Congress beginning with federal surplus/deficit spending historical data and a summary of the overall composition of the Administration's budget request. The charts then detail information on…

Views of the New Medicare Drug Law – Summary & Chartpack

This comprehensive survey of people on Medicare assesses their attitudes toward the new Medicare drug law. The survey provides detailed insight in their perceptions and opinions about the law, the Medicare-approved drug-discount card program and the new Medicare drug benefit set to begin in January 2006. It also assesses views…

Policy Workshop on Formularies and Medicare

Policy Workshop on Drug Formularies and MedicareThe Kaiser Family Foundation hosted a March 14, 2005 policy workshop on the use of drug formularies in the private sector and their potential implications for beneficiaries under the new Medicare drug benefit, set to go into effect January 1, 2006. The workshop involved…

Medicare Part D Issue Briefs

These issue briefs, prepared by the Centers for Medicare Advocacy, Inc., provide information about how the Medicare drug benefit will affect beneficiaries. The briefs address issues related to dual eligibles, residents of nursing home and assisted living facilities, and the Part D exceptions and appeals processes.Medicare Part D: Issues for…

Insights on Transitioning From Medicaid to the New Medicare Prescription Drug Benefit

The Kaiser Commission on Medicaid and the Uninsured convened a focus group of state Medicaid officials in November 2005 to discuss the impact of the new Medicare drug program on states and Medicaid enrollees. State insights on the transition of dual eligibles and some beneficiary experiences are discussed in new…

Issue Briefs Describe Changes in Private Plan Market and Effects on Medicare Beneficiaries

These two issue briefs describe the different types of private plan options available to people on Medicare, identify key characteristics of the organizations offering the new Medicare drug benefit, and analyze how companies are positioning themselves to attract Medicare enrollees.The Growth of Private Plans in Medicare, 2006The Landscape of Private…

Private Fee-For-Service Plans In Medicare: Rapid Growth and Future Implications

Kaiser Family Foundation Vice President Patricia Neuman, Ph.D., testified May 2007 before the House Ways and Means Subcommittee on Health on the rapid growth of private fee-for-service plans in the Medicare program and its implications for seniors and people with disabilities. Dr. Neuman is director of the Foundation’s Medicare Policy…

Medicare Part D 2008 Data Spotlight: Formularies

This spotlight examines the formularies (list of covered drugs) of Medicare stand-alone prescription drug plans in 2008, changes since 2006, and differences in how plans cover brand-name and generic drugs. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices. It…